MedTrace Logo

The Effect of Heat on Blood and Oxygen Flow Readings Part 2

NCT01992939 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2016-02-02

No results posted yet for this study

Summary

This is the second part of a research study in order to determine if using a specialized pulse oximetry probe with external heat pack will help obtain oxygen saturation (SaO2) and heart rate (HR) during monitoring for patients with peripheral vascular disease (PVD), vasoconstriction, and hypothermic extremities. The inability to obtain accurate SaO2 and pulse readings can lead to misdiagnosis, incorrect treatment, or procedures to be canceled. SaO2 and pulse readings are important to maintain patient stability during diagnostic testing, surgical procedures and monitoring while in critical care areas. Changes in SaO2 and pulse are important to monitor in order to be able to compensate for any decrease in patient oxygen saturations during hemodynamic monitoring.

The primary aim of this study is to determine if using a specialized pulse oximetry probe with external heat pack will improve oxygenation readings in order to obtain SaO2 and pulse readings in patients with PVD, vasoconstriction, and hypothermic extremities as compared to readings obtained from an arterial blood gas.

The hypothesis is using a specialized pulse oximetry probe with external heat pack will help obtain more accurate pulse oximetry readings consistent with values obtained with an arterial blood gas.

Conditions

  • Healthy
  • Peripheral Vascular Disease
  • Vasoconstriction

Interventions

OTHER

Specialized pulse oximetry probe with external heat pack

Pulse oximetry will be obtained using the specialized pulse oximetry probe with external heat pack for 45 minutes.

OTHER

Standard of Care Pulse Oximetry Probe

Pulse oximetry will be obtained using a standard of care pulse oximetry probe for 45 minutes.

Sponsors & Collaborators

  • Medline Industries

    collaborator INDUSTRY

  • VA Pittsburgh Healthcare System

    lead FED

Principal Investigators

  • Catherine Abee, CRT · VA Pittsburgh Healthcare System

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01992939 on ClinicalTrials.gov